These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 27150161
21. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, Sahasrabuddhe VV, Lamere B, Gage JC, Fetterman B, Darragh TM, Castle PE. AIDS; 2012 Nov 13; 26(17):2185-92. PubMed ID: 23018436 [Abstract] [Full Text] [Related]
22. Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population. Gustinucci D, Benevolo M, Cesarini E, Mancuso P, Passamonti B, Giaimo MD, Corvetti R, Nofrini V, Bulletti S, Malaspina M, Tintori B, Giorgi Rossi P, Umbria HPV Screening Working Group. Int J Cancer; 2022 Mar 15; 150(6):952-960. PubMed ID: 34706093 [Abstract] [Full Text] [Related]
24. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening. Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G, New Technologies for Cervical Cancer Screening Working Group. Int J Cancer; 2020 Oct 01; 147(7):1864-1873. PubMed ID: 32170961 [Abstract] [Full Text] [Related]
26. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women. Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M, the New Technology for Cervical Cancer 2 Working Group. J Natl Cancer Inst; 2021 Mar 01; 113(3):292-300. PubMed ID: 32745170 [Abstract] [Full Text] [Related]
29. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Frega A, Pavone M, Sesti F, Leone C, Bianchi P, Cozza G, Colombrino C, Lukic A, Marziani R, De Sanctis L, Delli Carpini G, Caserta D, Ciavattini A. Eur Rev Med Pharmacol Sci; 2019 Dec 01; 23(24):10672-10677. PubMed ID: 31858534 [Abstract] [Full Text] [Related]
39. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China. Zhang SK, Jia MM, Zhao DM, Wu ZN, Guo Z, Liu YL, Guo PP, Chen Q, Cao XQ, Liu SZ, Chen W, Sun XB. Cancer Epidemiol; 2019 Apr 01; 59():123-128. PubMed ID: 30739069 [Abstract] [Full Text] [Related]
40. Evaluation of p16/Ki-67 Dual-Stained Cytology in Triaging HPV-Positive Women during Cervical Cancer Screening. Hu Y, Hong Z, Gu L, Xie L, Yang B, Dai H, Chen H, Zhang B, Huang L, Liu Z, Cheng J, Zhang Y, Zhang Y, Lin J, Qiu L, Di W. Cancer Epidemiol Biomarkers Prev; 2020 Jun 01; 29(6):1246-1252. PubMed ID: 32156721 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]